Relationship of fasting glucose and longitudinal Alzheimer's disease imaging markers.

Honea, Robyn A; John, Casey S; Green, Zachary D; Kueck, Paul J; Taylor, Matthew K; Lepping, Rebecca J; Townley, Ryan; Vidoni, Eric D; Burns, Jeffery M; Morris, Jill K

Honea, Robyn A; John, Casey S; Green, Zachary D; Kueck, Paul J; Taylor, Matthew K; Lepping, Rebecca J; Townley, Ryan; Vidoni, Eric D; Burns, Jeffery M; Morris, Jill K.

Afiliação

Honea RA; University of Kansas Alzheimer's Disease Research Center Kansas City Kansas USA.
John CS; Department of Neurology University of Kansas Medical Center Kansas City Kansas USA.
Green ZD; University of Kansas Alzheimer's Disease Research Center Kansas City Kansas USA.
Kueck PJ; Department of Neurology University of Kansas Medical Center Kansas City Kansas USA.
Taylor MK; University of Kansas Alzheimer's Disease Research Center Kansas City Kansas USA.
Lepping RJ; Department of Neurology University of Kansas Medical Center Kansas City Kansas USA.
Townley R; University of Kansas Alzheimer's Disease Research Center Kansas City Kansas USA.
Vidoni ED; Department of Neurology University of Kansas Medical Center Kansas City Kansas USA.
Burns JM; Department of Dietetics and Nutrition University of Kansas Medical Center Kansas City Kansas USA.
Morris JK; Hoglund Biomedical Imaging Center University of Kansas Medical Center Kansas City Kansas USA.

Alzheimers Dement (N Y) ; 8(1): e12239, 2022.

Article em En | MEDLINE | ID: mdl-35128029

Palavras-chave

Alzheimer's disease; amyloid; glucose; hippocampus; imaging; metabolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Alzheimers Dement (N Y) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google